{"organizations": [], "uuid": "de5ced597c8f18eb8dc91c7fabf5ab593e0ec978", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-cumberland-pharmaceuticals-expands/brief-cumberland-pharmaceuticals-expands-into-oncology-support-idUSFWN1RM0NH", "country": "US", "domain_rank": 408, "title": "BRIEF-Cumberland Pharmaceuticals Expands Into Oncology Support", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-09T16:18:00.000+03:00", "replies_count": 0, "uuid": "de5ced597c8f18eb8dc91c7fabf5ab593e0ec978"}, "author": "", "url": "https://www.reuters.com/article/brief-cumberland-pharmaceuticals-expands/brief-cumberland-pharmaceuticals-expands-into-oncology-support-idUSFWN1RM0NH", "ord_in_thread": 0, "title": "BRIEF-Cumberland Pharmaceuticals Expands Into Oncology Support", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "cumberland pharmaceuticals inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 9, 2018 / 1:20 PM / Updated 11 minutes ago BRIEF-Cumberland Pharmaceuticals Expands Into Oncology Support Reuters Staff \nApril 9 (Reuters) - Cumberland Pharmaceuticals Inc: \n* CUMBERLAND PHARMACEUTICALS EXPANDS INTO ONCOLOGY SUPPORT Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-09T16:18:00.000+03:00", "crawled": "2018-04-09T16:36:13.003+03:00", "highlightTitle": ""}